The presentation and posters will be available on the publications page of Avidity's website at https://www.aviditybiosciences.com following the conference.
Novartis’ RNA production facility in Schweizerhalle, Switzerland. Novartis is acquiring Avidity Biosciences for approximately $12 billion, in a deal designed to bolster the buyer’s neuroscience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results